N. M. Kapranov

[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways].

A. Sudarikov, V. Surin, K. Zarubina, 2020, Terapevticheskii arkhiv.

[Li-Fraumeni syndrome in adult patients with acute lymphoblastic leukemia].

A. Sudarikov, V. Surin, E. Parovichnikova, 2021, Terapevticheskii arkhiv.

MORPHOLOGY AND DISTRIBUTION OF Α-NAPHTHYL BUTIRATE ESTERASE AND NAPHTHOL AS-D CHLOROACETATE ESTERASE IN NORMAL MYELOMONOCYTIC PRECURSORS STUDIED BY THE CELL MICROARRAY

F. Ataullakhanov, O. Fedyanina, N. M. Kapranov, 2016 .

BCR/ABL, IKZF deletions and FLT3-ITD as the targets for relapsed/refractory B-cell acute lymphoblastic leukemia treatment: Blinatumomab combined with Tyrosine kinase inhibitors and ATRA

E. Parovichnikova, O. Gavrilina, S. Bondarenko, 2020 .

Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial

A. Sudarikov, O. Samoilova, E. Parovichnikova, 2023, Oncohematology.

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

E. Parovichnikova, I. Galtseva, A. Sokolov, 2016 .

Molecular Changes in Immunological Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells in Lymphoid Neoplasia.

M. Lagarkova, O. Pobeguts, E. Parovichnikova, 2024, Biochemistry. Biokhimiia.